Fisher Asset Management
NVAX icon

Fisher Asset Management’s Novavax NVAX Stock Holding History

Fisher Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-7,212
Closed -$371K – 983
2022
Q2 		$371K Sell
7,212
-141
-2% -$7.3K ﹤0.01% 766
2022
Q1 		$542K Buy
7,353
+5
+0.1% +$446 ﹤0.01% 719
2021
Q4 		$1.05M Buy
7,348
+107
+1% +$18.4K ﹤0.01% 634
2021
Q3 		$1.5M Buy
7,241
+43
+0.6% +$9.48K ﹤0.01% 560
2021
Q2 		$1.53M Sell
7,198
-80
-1% -$14.7K ﹤0.01% 557
2021
Q1 		$1.32M Sell
7,278
-69
-0.9% -$13.8K ﹤0.01% 576
2020
Q4 		$819K Buy
7,347
+150
+2% +$15.9K ﹤0.01% 622
2020
Q3 		$780K Hold
7,197
– – ﹤0.01% 590
2020
Q2 		$600K Buy
+7,197
New +$275K ﹤0.01% 635
2019
Q2 		– Sell
-7,703
Closed -$85K – 856
2019
Q1 		$85K Buy
7,703
+470
+6% +$14.8K ﹤0.01% 781
2018
Q4 		$266K Buy
7,233
+35
+0.5% +$1.36K ﹤0.01% 730
2018
Q3 		$271K Hold
7,198
– – ﹤0.01% 725
2018
Q2 		$193K Hold
7,198
– – ﹤0.01% 771
2018
Q1 		$302K Hold
7,198
– – ﹤0.01% 677
2017
Q4 		$179K Buy
+7,198
New +$176K ﹤0.01% 832

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $23.5B AUM 33.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Fisher Asset Management's NVAX Position: Q3 2022 in Review

Fisher Asset Management sold out of Novavax (NVAX) in Q3 2022, closing a stake of 7,212 shares — an estimated $371K sold.

Fisher Asset Management first reported a position in NVAX in Q4 2017 and held it in 15 quarters. The position peaked at $1.53M in Q2 2021. 253 funds tracked by Wall St. Rank hold NVAX as of Q3 2022.

  • Fisher Asset Management reported no remaining Novavax position as of Q3 2022 after selling out during the quarter.
  • Fisher Asset Management sold 7,212 Novavax shares in Q3 2022, an estimated $371K.
  • Fisher Asset Management first reported a position in Novavax in Q4 2017 and held it in 15 quarters.
  • Fisher Asset Management's Novavax position peaked at $1.53M in Q2 2021.
  • 253 funds tracked by Wall St. Rank held Novavax as of Q3 2022.

Based on Fisher Asset Management's 13F filing for Q3 2022, filed 8 Nov 2022.